Announcement Archive

Announcement Archive

News Archive

New research group “Computational Virology” at TWINCORE

Group leader Chris Lauber funded by RESIST

 

Fraunhofer Research consortium iCAIR® makes use of synergies to develop new medications against SARS-CoV-2

With its rapid spread around the world, the new coronavirus SARS-CoV-2 has triggered a public health emergency of international concern. To date,…

Searching for drugs against SARS-CoV-2

RESIST-Scientist Professor Pietschmann, head of the TWINCORE Insitute for Experimental Virology, leads the German part of an international consortium…

Epigenetic DNA modifications can predict asthma and rhinitis

Researchers from the CiiM and University of Groningen identify biomarkers in the nasal airways

First robust cell culture model for the hepatitis E virus

A mutation switches the turbo on during virus replication. This is a blessing for research.

How the body produces an endogenous antibiotic with anti-inflammatory effects

HZI and TWINCORE researchers give insights into itaconic acid synthesis For a long time, itaconic acid was only known as a metabolic product of…

Twelfth VPM Days at TWINCORE

On 12 and 13 September, the 12th International VPM Days took place at TWINCORE in Hannover. More than 20 international speakers and almost 100…

How cytomegaloviruses are kept in check

TWINCORE researchers are decoding cellular body recognition mechanisms that control the cytomegalovirus Ein Großteil der Weltbevölkerung ist mit dem…

Eliminating hepatitis C viruses effectively

TWINCORE researchers identify target on the viral envelope and develop customised agents. The treatment of hepatitis C has been based on specific…